LG
Therapeutic Areas
Ceribell Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Ceribell System with Clarity® | Detection of Non-Convulsive Seizures & Status Epilepticus | FDA Cleared |
| Ceribell System | Delirium Monitoring | Development |
| Clarity Algorithm v6 | Seizure Detection & Burden Quantification | FDA Cleared |
| Future AI Algorithms | Neurological Conditions Beyond Seizures | Research |
Leadership Team at Ceribell
JC
Jane Chao, PhD
President, Chief Executive Officer, Co-Founder, and Director
RW
Raymond Woo, PhD
Chief Technology Officer
SB
Scott Blumberg
Chief Financial Officer
SM
Sean Manni
Chief Revenue Officer
LD
Louisa Daniels
General Counsel
PV
Paul Vespa, MD
Neurologist & Neurocritical Care (UCLA) - Featured Clinician
MK
Mary Kay Bader, CCRN, CNRN
Nurse (Mission Hospital) - Featured Clinician
MB
Margo Block, DO
Neurologist (University of Kansas Medical Center) - Featured Clinician
DO
Daiwai Olson, PhD
Nurse (UT Southwestern) - Featured Clinician
PD
Parshaw Dorriz, MD
Neurologist (Mission Hospital) - Featured Clinician